Radiation and ethylene oxide terminal sterilization experiences with drug eluting stent products

AAPS PharmSciTech

Volumn 12, Issue 4, 2011, Pages 1116-1126

  Lambert, Byron J ^a   Mendelson, Todd A ^a   Craven, Michael D ^a  

^a ABBOTT VASCULAR   (United States)

Author keywords

combination devices; drug eluting stents; ethylene oxide sterilization; material compatibility; radiation sterilization

Indexed keywords

ETHYLENE OXIDE;

BARE METAL STENT; BIOCOMPATIBILITY; CATHETER; DEVICE; DRUG ELUTING STENT; ELECTRON BEAM STERILIZATION; GAMMA STERILIZATION; GUIDEWIRE; HEART VALVE PROSTHESIS; HUMAN; INSTRUMENT STERILIZATION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION STERILIZATION; REVIEW; VESSEL CLOSURE DEVICE; X RAY STERILIZATION;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; DISINFECTANTS; DRUG-ELUTING STENTS; EQUIPMENT SAFETY; ETHYLENE OXIDE; GAMMA RAYS; PATIENT SAFETY; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; QUALITY CONTROL; STERILIZATION; X-RAYS;

EID: 83455198257     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9644-8     Document Type: Review

References (46)

1. United States Code of Federal Regulations, Title 21, Volume 1, Part 3, Section 3.2 (e), Definitions.
2. PharmaLive.com. Special reports: drug-delivery review and outlook. 2010.
3. Conroy S. The industry's Trifecta: drugs, devices and biologics. MD&DI; 2009. www.devicelink.com/mddi. Accessed 31 Jan 2011.
4. DL Kereiakes, et al. 2010 Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention JACC Cardiovasc Interv 3 12 1229 39 21232716 10.1016/j.jcin.2010.09.014
5. A Caixeta, et al. 2010 Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents JACC Cardiovasc Interv 3 12 1220 8 21232715 10.1016/j.jcin.2010.07.017
6. Serruys PW, Waksman R, Onuma Y, editors. Vascular restoration therapy, EuroIntervention supplement. 2009;5 Suppl F. Supplement is entitled and dedicated to the theme of vascular restoration therapy and initial devices.
7. PW Serruys, et al. 2009 A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 897 910 19286089 10.1016/S0140-6736(09)60325-1 1:CAS:528: DC%2BD1MXjtFKqtro%3D
8. MedMarket Diligence report #C245, worldwide market for drug-eluting, bare and other coronary stents. 2009;2008-2017.
9. Lambert BJ. Sterilisation: material compatibility challenges and guidance for combination products. European Medical Device Technology. 2010;21-25.
10. ISO/TS 11139:2006. Sterilization of health care products-vocabulary. 2006.
11. Favero MS. Sterility assurance: concepts for patient safety, in disinfection, sterilization and antisepsis: principles and practices in healthcare facilities, chapter 12. In: Rutala WA, editor. Association for Professionals in Infection Control and Epidemiology. DC.: Washington; 2001. p. 110-9.
12. Lolas AG. US FDA, Center for Drug Evaluation and Research, Regulatory Approaches for Novel Processing and Innovative Products, invited presentation at the 15th International Meeting on Radiation Processing. London: September 2008.
13. ANSI/AAMI ST67:2011. Sterilization of health care products-Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled "STERILE". See Annex A, Background and historical application of sterility assurance.
14. ANSI/AAMI ST67:2011. Sterilization of health care products-Requirements and guidance for selecting a sterility assurance level (SAL) for products labeled "STERILE". See Annex B, Examples of terminally sterilized products and sterility assurance levels that have historically been selected.
15. ISO TC 198. ISO/Draft International Standard, Aseptic processing of health care products, Part 7: Alternate processes for atypical medical devices and combination devices.
16. AAMI TIR 17:2008. Compatibility of materials subject to sterilization. 2008.
17. AAMI TIR37:2007. Sterilization of health care products-radiation-guidance on sterilization of human tissue-based products. The need for tissue product sterilization drove the development of this document. 2007
18. Jarvis WR, Epidemiology Branch. Nosocomial outbreaks: the Centers for Disease Control's Hospital Infections Program Experience, 1980-1990. In: Martone WJ, Garnder JS, editors. Proceedings of the 3rd decennial international conference on nosocomial infections. Am. J. Med 1991;91 Suppl 3B. p. 101S-106S.
19. Jarvis WR. Centers for Disease Control and Prevention, Hospital Infections Program on-site outbreaks investigations, 1990-1999: how often are germicides or sterilants the sources. In: Rutala WR, editor. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2001.
20. Higashi JM, Marchant RE. Implant infections. In: Recum AFV, editor. Handbook of biomaterials evaluation: scientific, technical, and clinical testing of implant materials. Philadelphia: Taylor & Francis; 1999. p. 493-506.
21. RTI, Proven Record of Safety, Sterilization Process. http://www.rtix.com/ safety/sterilization-processes. Accessed 30 Jan 2011.
22. ISO 14937:2009, Sterilization of health care products-general requirements for characterization of a sterilizing agent and the development, validation, and routing control of a sterilization process for medical devices. See introduction. 2009.
23. ANSI/AAMI ST67:2003. Sterilization of health care products-requirements for products labeled "STERILE". 2003.
24. ISO 11137-1 Sterilization of health care products-radiation-part 1: requirements for development, validation, and routine control of a sterilization process for medical devices.
25. Kowalski JB, Morrison RF. Sterilization of implants and devices. In: Ratner BD et al., editors. Biomaterials science: an introduction to materials in medicine. San Diego: Elsevier Academic; 2004. p. 754-9.
26. ISO 11135-1: 2007. Sterilisation of healthcare products, ethylene oxide, part I: requirements for development, validation and routine control of a sterilisation process for medical devices, Annex B, Conservative determination of lethal rate of the sterilization process-Overkill approach. 2007.
27. Hemmerich KJ, et al. Sterilization methods stand the test of time. Medical Device and Diagnostic Industry. 2004;26(8). http://www.mddionline.com/ article/sterilization-methods-stand-test-time. Accessed 30 Jan 2011.
28. ISO 11135-1: 2007. Sterilisation of healthcare products, ethylene oxide, part I: requirements for development, validation and routine control of a sterilisation process for medical devices. 2007.
29. C Phillips 1949 The sterilizing action of gaseous ethylene oxide II. Sterilization of contaminated objects with ethylene AM J HTO 50 280 8 1:CAS:528:DyaG3cXjsVehtw%3D%3D
30. J Silverman 1981 Radiation processing: the industrial applications of radiation chemistry J Chem Ed 58 168 73 10.1021/ed058p168
31. ANSI/AAMI/ISO 14937:2009. Sterilization of health care products-general requirements for characterization of a sterilizing agent and the development, validation, and routing control of a sterilization process for medical devices. 2009.
32. Committee for Proprietary Medical Products (CPMP) Decision Trees for the Selection of Sterilisation Methods (CPMP/QWP/054/98). Annex to note for guidance on developmental pharmaceuticals (CPMP/QWP/155/96).
33. IP Matthews C Gibson AH Samuel 1994 Sterilisation of implantable devices Clin Mater 15 191 215 10172076 10.1016/0267-6605(94)90082-5 1:STN:280: DyaK2cbgvVGnuw%3D%3D (Pubitemid 24127787)
34. GCC Mendes TRS Brandão CLM Silva 2007 Ethylene oxide sterilization of medical devices: a review Am J Infect Control. 35 574 81 17980234 10.1016/j.ajic.2006.10.014 (Pubitemid 350007834)
35. WG Lindboe K Hayakawa 1993 Comparative terminal sterilization J Parenter Sci Technol 47 3 138 41 8360807 1:STN:280:DyaK3szmslKksQ%3D%3D This article addresses moist heat sterilization of pharmaceuticals (Pubitemid 23180786)
36. Serruys PW, Ong ATL, Piek JJ, et al. A randomised comparison of a durable polymer everolimus-eluting coronary stent with a bare metal coronary stent: the SPIRIT first trial. EuroIntervention. 2005. p. 58-65.
37. J Oberhauser S Hossainy R Rapoza 2009 Design principles and performance of bioresorbable polymeric vascular scaffolds EuroInterv Suppl 5 Suppl F F15 22
38. The XIENCE V® everolimus eluting coronary stent system instructions for use, p. 53. 2010. http://www.abbottvascular.com/us/ifu.html. Accessed 30 Jan 2011.
39. JSC Loo CP Ooi FYC Boey 2005 Degradation of poly(lactide-co-glycolide) (PLGA) and poly(l-lactide) (PLLA) by electron beam radiation Biomaterials 26 12 1359 67 15482823 10.1016/j.biomaterials.2004.05.001 1:CAS:528: DC%2BD2cXosFSltbw%3D (Pubitemid 39336512)
40. Güven O. The use of size exclusion chromatography in the studies of crosslinking and chain scission in polymers. In: Güven O, editor. Crosslinking and scission in polymers. Dordrecht: Kluwer Academic; 1990. p. 39-250.
41. ISO 11137-1:2006. Sterilization of health care products-radiation-part 1: requirements for development, validation and routine control of a sterilization process for medical devices. Clause 8, Process Definition. 2006.
42. AAMI TIR 33:2005. Sterilization of health care products-radiation- substantiation of a selected sterilization dose-method VDmax. 2005.
43. AAMI TIR 40:2009. Sterilization of health care products-radiation- guidance on dose setting utilizing a modified method 2. 2009.
44. BJ Lambert FW Tang 2000 Rationale for practical medical device accelerated aging programs in AAMI TIR17 Radiat Phys Chem 57 3-6 349 53 10.1016/S0969-806X(99)00403-X 1:CAS:528:DC%2BD3cXivFOru78%3D (Pubitemid 30154201)
45. ICH Q1A (R2). Stability testing of new drug substances and products. 2003.
46. J. Kulla J, et al. Sterilising combination products using oxides of nitrogen. Medical Device and Diagnostic Industry. 2009;31(3). www.mddionline.com/article/sterilizingcombination-products-using-oxides- nitrogen. Accessed 30 Jan 2011.